Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 847985, 9 pages
http://dx.doi.org/10.1155/2015/847985
Review Article

Altered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for “Antiphospholipid Antibodies”

1Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy
2Department of Hematology, Oncology and Molecular Medicine, National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy
3Laboratory of Experimental Medicine and Environmental Pathology, Sabina Universitas, Via dell’Elettronica, 02100 Rieti, Italy
4Italian Institute of Technology, Via Morego 30, 16136 Genoa, Italy

Received 27 July 2015; Accepted 6 September 2015

Academic Editor: Douglas C. Hooper

Copyright © 2015 Valeria Manganelli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Kerr, A. H. Wyllie, and A. R. Currie, “Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics,” British Journal of Cancer, vol. 26, no. 4, pp. 239–257, 1972. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Häcker, “The morphology of apoptosis,” Cell and Tissue Research, vol. 301, no. 1, pp. 5–17, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. M. O. Hengartner, “The biochemistry of apoptosis,” Nature, vol. 407, no. 6805, pp. 770–776, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Boya, K. Andreau, D. Poncet et al., “Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion,” The Journal of Experimental Medicine, vol. 197, no. 10, pp. 1323–1334, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. C. Peitsch, H. G. Mannherz, and J. Tschopp, “The apoptosis endonucleases: cleaning up after cell death?” Trends in Cell Biology, vol. 4, no. 2, pp. 37–41, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. R. C. Taylor, S. P. Cullen, and S. J. Martin, “Apoptosis: controlled demolition at the cellular level,” Nature Reviews Molecular Cell Biology, vol. 9, no. 3, pp. 231–241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. I. M. Cristea and M. D. Esposti, “Membrane lipids and cell death: an overview,” Chemistry and Physics of Lipids, vol. 129, no. 2, pp. 133–160, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Yamaji-Hasegawa and M. Tsujimoto, “Asymmetric distribution of phospholipids in biomembranes,” Biological and Pharmaceutical Bulletin, vol. 29, no. 8, pp. 1547–1553, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. V. A. Fadok, D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton, and P. M. Henson, “Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages,” The Journal of Immunology, vol. 148, no. 7, pp. 2207–2216, 1992. View at Google Scholar · View at Scopus
  10. S. J. Martin, C. P. M. Reutelingsperger, A. J. McGahon et al., “Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl,” Journal of Experimental Medicine, vol. 182, no. 5, pp. 1545–1556, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. V. A. Fadok, D. L. Bratton, D. M. Rose, A. Pearson, R. A. B. Ezekewitz, and P. M. Henson, “A receptor for phosphatidylserine-specific clearance of apoptotic cells,” Nature, vol. 405, no. 6782, pp. 85–90, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. J. E. Mitchell, M. Cvetanovic, N. Tibrewal et al., “The presumptive phosphatidylserine receptor is dispensable for innate anti-inflammatory recognition and clearance of apoptotic cells,” The Journal of Biological Chemistry, vol. 281, no. 9, pp. 5718–5725, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Liu, R. F. Epand, D. Durrant et al., “Role of phospholipid scramblase 3 in the regulation of tumor necrosis factor-alpha-induced apoptosis,” Biochemistry, vol. 47, no. 15, pp. 4518–4529, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Sorice, A. Circella, R. Misasi et al., “Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipid antibodies,” Clinical and Experimental Immunology, vol. 122, no. 2, pp. 277–284, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Crimi and M. D. Esposti, “Apoptosis-induced changes in mitochondrial lipids,” Biochimica et Biophysica Acta, vol. 1813, no. 4, pp. 551–557, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Zamzami, S. A. Susin, P. Marchetti et al., “Mitochondrial control of nuclear apoptosis,” The Journal of Experimental Medicine, vol. 183, no. 4, pp. 1533–1544, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. J.-L. Vayssière, P. X. Petit, Y. Risler, and B. Mignotte, “Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 24, pp. 11752–11756, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. P. X. Petit, H. Lecoeur, E. Zorn, C. Dauguet, B. Mignotte, and M.-L. Gougeon, “Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis,” Journal of Cell Biology, vol. 130, no. 1, pp. 157–167, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. D. M. Hockenbery, Z. N. Oltvai, X.-M. Yin, C. L. Milliman, and S. J. Korsmeyer, “Bcl-2 functions in an antioxidant pathway to prevent apoptosis,” Cell, vol. 75, no. 2, pp. 241–251, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Boveris and B. Chance, “The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen,” Biochemical Journal, vol. 134, no. 3, pp. 707–716, 1973. View at Publisher · View at Google Scholar · View at Scopus
  21. L. A. Casciola-Rosen, D. K. Miller, G. J. Anhalt, and A. Rosen, “Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death,” The Journal of Biological Chemistry, vol. 269, no. 49, pp. 30757–30760, 1994. View at Google Scholar · View at Scopus
  22. C. A. Casiano, S. J. Martin, D. R. Green, and E. M. Tan, “Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)- mediated T cell apoptosis,” The Journal of Experimental Medicine, vol. 184, no. 2, pp. 765–770, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Macho, M. Castedo, P. Marchetti et al., “Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers,” Blood, vol. 86, no. 7, pp. 2481–2487, 1995. View at Google Scholar · View at Scopus
  24. M. Schlame, D. Rua, and M. L. Greenberg, “The biosynthesis and functional role of cardiolipin,” Progress in Lipid Research, vol. 39, no. 3, pp. 257–288, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Moreau and C. Cassagne, “Phospholipid trafficking and membrane biogenesis,” Biochimica et Biophysica Acta, vol. 1197, no. 3, pp. 257–290, 1994. View at Google Scholar · View at Scopus
  26. A. Zachowski, “Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement,” Biochemical Journal, vol. 294, no. 1, pp. 1–14, 1993. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Ouasti, P. Matarrese, R. Paddon et al., “Death receptor ligation triggers membrane scrambling between Golgi and mitochondria,” Cell Death and Differentiation, vol. 14, no. 3, pp. 453–461, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Matarrese, V. Manganelli, T. Garofalo et al., “Endosomal compartment contributes to the propagation of CD95/Fas-mediated signals in type II cells,” Biochemical Journal, vol. 413, no. 3, pp. 467–478, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Degli Esposti, “Organelle intermixing and membrane scrambling in cell death,” Methods in Enzymology, vol. 442, pp. 421–438, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. N. C. Robinson, “Functional binding of cardiolipin to cytochrome c oxidase,” Journal of Bioenergetics and Biomembranes, vol. 25, no. 2, pp. 153–163, 1993. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Mahesh, H.-S. Leong, A. McCormack, P. Sarathchandra, A. Holder, and M. L. Rose, “Autoantibodies to vimentin cause accelerated rejection of cardiac allografts,” The American Journal of Pathology, vol. 170, no. 4, pp. 1415–1427, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. R. H. Houtkooper and F. M. Vaz, “Cardiolipin, the heart of mitochondrial metabolism,” Cellular and Molecular Life Sciences, vol. 65, no. 16, pp. 2493–2506, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Mileykovskaya, M. Zhang, and W. Dowhan, “Cardiolipin in energy transducing membranes,” Biochemistry, vol. 70, no. 2, pp. 154–158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Ardail, J.-P. Privat, M. Egret-Charlier, C. Levrat, F. Lerme, and P. Louisot, “Mitochondrial contact sites: lipid composition and dynamics,” The Journal of Biological Chemistry, vol. 265, no. 31, pp. 18797–18802, 1990. View at Google Scholar · View at Scopus
  35. M. G. Fernandez, L. Troiano, L. Moretti et al., “Early changes in intramitochondrial cardiolipin distribution during apoptosis,” Cell Growth & Differentiation, vol. 13, no. 9, pp. 449–455, 2002. View at Google Scholar · View at Scopus
  36. A. J. Chicco and G. C. Sparagna, “Role of cardiolipin alterations in mitochondrial dysfunction and disease,” The American Journal of Physiology—Cell Physiology, vol. 292, no. 1, pp. C33–C44, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Vreken, F. Valianpour, L. G. Nijtmans et al., “Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome,” Biochemical and Biophysical Research Communications, vol. 279, no. 2, pp. 378–382, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. M. W. Fariss, C. B. Chan, M. Patel, B. Van Houten, and S. Orrenius, “Role of mitochondria in toxic oxidative stress,” Molecular Interventions, vol. 5, no. 2, pp. 94–111, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. X. X. Li, B. Tsoi, Y. F. Li, H. Kurihara, and R. R. He, “Cardiolipin and its different properties in mitophagy and apoptosis,” Journal of Histochemistry & Cytochemistry, vol. 63, no. 5, pp. 301–311, 2015. View at Publisher · View at Google Scholar
  40. F. Gonzalvez and E. Gottlieb, “Cardiolipin: setting the beat of apoptosis,” Apoptosis, vol. 12, no. 5, pp. 877–885, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Kuwana, M. R. Mackey, G. Perkins et al., “Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane,” Cell, vol. 111, no. 3, pp. 331–342, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. X. Roucou, S. Montessuit, B. Antonsson, and J.-C. Martinou, “Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein,” Biochemical Journal, vol. 368, no. 3, pp. 915–921, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Degli Esposti, I. M. Cristea, S. J. Gaskell, Y. Nakao, and C. Dive, “Proapoptotic Bid binds to monolysocardiolipin, a new molecular connection between mitochondrial membranes and cell death,” Cell Death & Differentiation, vol. 10, no. 12, pp. 1300–1309, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Gonzalvez, Z. T. Schug, R. H. Houtkooper et al., “Cardiolipin provides an essential activating platform for caspase-8 on mitochondria,” Journal of Cell Biology, vol. 183, no. 4, pp. 681–696, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. O. Jalmar, A. J. García-Sáez, L. Berland, F. Gonzalvez, and P. X. Petit, “Giant unilamellar vesicles (GUVs) as a new tool for analysis of caspase-8/Bid-FL complex binding to cardiolipin and its functional activity,” Cell Death and Disease, vol. 1, no. 12, article e103, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. O. Jalmar, L. François-Moutal, A.-J. García-Sáez et al., “Caspase-8 binding to cardiolipin in giant unilamellar vesicles provides a functional docking platform for Bid,” PLoS ONE, vol. 8, no. 2, Article ID e55250, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Kantari and H. Walczak, “Caspase-8 and Bid: caught in the act between death receptors and mitochondria,” Biochimica et Biophysica Acta, vol. 1813, no. 4, pp. 558–563, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. Z. T. Schug and E. Gottlieb, “Cardiolipin acts as a mitochondrial signalling platform to launch apoptosis,” Biochimica et Biophysica Acta, vol. 1788, no. 10, pp. 2022–2031, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. K. J. Oh, S. Barbuto, N. Meyer, R.-S. Kim, R. J. Collier, and S. J. Korsmeyer, “Conformational changes in BID, a pro-apoptotic BCL-2 family member, upon membrane binding. A site-directed spin labeling study,” The Journal of Biological Chemistry, vol. 280, no. 1, pp. 753–767, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Garofalo, A. M. Giammarioli, R. Misasi et al., “Lipid microdomains contribute to apoptosis-associated modifications of mitochondria in T cells,” Cell Death & Differentiation, vol. 12, no. 11, pp. 1378–1389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. W. Malorni, T. Garofalo, A. Tinari et al., “Analyzing lipid raft dynamics during cell apoptosis,” Methods in Enzymology, vol. 442, pp. 125–140, 2008. View at Publisher · View at Google Scholar
  52. W. Malorni, A. M. Giammarioli, T. Garofalo, and M. Sorice, “Dynamics of lipid raft components during lymphocyte apoptosis: the paradigmatic role of GD3,” Apoptosis, vol. 12, no. 5, pp. 941–949, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Garofalo, A. Tinari, P. Matarrese et al., “Do mitochondria act as ‘cargo boats’ in the journey of GD3 to the nucleus during apoptosis?” FEBS Letters, vol. 581, no. 21, pp. 3899–3903, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Sorice, V. Manganelli, P. Matarrese et al., “Cardiolipin-enriched raft-like microdomains are essential activating platforms for apoptotic signals on mitochondria,” FEBS Letters, vol. 583, no. 15, pp. 2447–2450, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Karbowski, Y.-J. Lee, B. Gaume et al., “Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis,” Journal of Cell Biology, vol. 159, no. 6, pp. 931–938, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Hovius, J. Thijssen, P. van der Linden, K. Nicolay, and B. de Kruijff, “Phospholipid asymmetry of the outer membrane of rat liver mitochondria. Evidence for the presence of cardiolipin on the outside of the outer membrane,” FEBS Letters, vol. 330, no. 1, pp. 71–76, 1993. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Nicolay, M. Rojo, T. Wallimann, R. Demel, and R. Hovius, “The role of contact sites between inner and outer mitochondrial membrane in energy transfer,” Biochimica et Biophysica Acta, vol. 1018, no. 2-3, pp. 229–233, 1990. View at Publisher · View at Google Scholar · View at Scopus
  58. R. Hovius, H. Lambrechts, K. Nicolay, and B. de Kruijff, “Improved methods to isolate and subfractionate rat liver mitochondria. Lipid composition of the inner and outer membrane,” Biochimica et Biophysica Acta, vol. 1021, no. 2, pp. 217–226, 1990. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Lutter, M. Fang, X. Luo, M. Nishijima, X.-S. Xie, and X. Wang, “Cardiolipin provides specificity for targeting of tBid to mitochondria,” Nature Cell Biology, vol. 2, no. 10, pp. 754–756, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. T. K. Rostovtseva, H. Boukari, A. Antignani et al., “Bax activates endophilin B1 oligomerization and lipid membrane vesiculation,” The Journal of Biological Chemistry, vol. 284, no. 49, pp. 34390–34399, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Manara, J. Lindsay, M. Marchioretto, A. Manara et al., “Bid binding to negatively charged phospholipids may not be required for its pro-apoptotic activity in vivo,” Biochimica et Biophysica Acta, vol. 1791, no. 10, pp. 997–1010, 2009. View at Publisher · View at Google Scholar
  62. G. Kudla, S. Montessuit, R. Eskes et al., “The destabilization of lipid membranes induced by the C-terminal fragment of caspase 8-cleaved Bid is inhibited by the N-terminal fragment,” The Journal of Biological Chemistry, vol. 275, no. 30, pp. 22713–22718, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Grinberg, R. Sarig, Y. Zaltsman et al., “tBID homooligomerizes in the mitochondrial membrane to induce apoptosis,” The Journal of Biological Chemistry, vol. 277, no. 14, pp. 12237–12245, 2002. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Sorice, A. Circella, I. M. Cristea et al., “Cardiolipin and its metabolites move from mitochondria to other cellular membranes during death receptor-mediated apoptosis,” Cell Death and Differentiation, vol. 11, no. 10, pp. 1133–1145, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. M. D. Esposti, J. T. Erler, J. A. Hickman, and C. Dive, “Bid, a widely expressed proapoptotic protein of the Bcl-2 family, displays lipid transfer activity,” Molecular and Cellular Biology, vol. 21, no. 21, pp. 7268–7276, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. D. B. Ostrander, G. C. Sparagna, A. A. Amoscato, J. B. McMillin, and W. Dowhan, “Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis,” The Journal of Biological Chemistry, vol. 276, no. 41, pp. 38061–38067, 2001. View at Google Scholar · View at Scopus
  67. K. Nomura, H. Imai, T. Koumura, T. Kobayashi, and Y. Nakagawa, “Mitochondrial phospholipid hydroperoxide glutathione peroxidase inhibits the release of cytochrome c from mitochondria by suppressing the peroxidation of cardiolipin in hypoglycaemia-induced apoptosis,” Biochemical Journal, vol. 351, no. 1, pp. 183–193, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. J.-C. Martinou and D. R. Green, “Breaking the mitochondrial barrier,” Nature Reviews Molecular Cell Biology, vol. 2, no. 1, pp. 63–67, 2001. View at Publisher · View at Google Scholar · View at Scopus
  69. G.-I. Atsumi, M. Tajima, A. Hadano, Y. Nakatani, M. Murakami, and I. Kudot, “Fas-induced arachidonic acid release is mediated by Ca2+-independent phospholipase A2 but not cytosolic phospholipase A2, which undergoes proteolytic inactivation,” The Journal of Biological Chemistry, vol. 273, no. 22, pp. 13870–13877, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Maccarrone, G. Melino, and A. Finazzi-Agrò, “Lipoxygenases and their involvement in programmed cell death,” Cell Death & Differentiation, vol. 8, no. 8, pp. 776–784, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. D. W. Voehringer, D. L. Hirschberg, J. Xiao et al., “Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 6, pp. 2680–2685, 2000. View at Publisher · View at Google Scholar · View at Scopus
  72. M. D. Esposti, I. Hatzinisiriou, H. McLennan, and S. Ralph, “Bcl-2 and mitochondrial oxygen radicals. New approaches with reactive oxygen species-sensitive probes,” The Journal of Biological Chemistry, vol. 274, no. 42, pp. 29831–29837, 1999. View at Publisher · View at Google Scholar · View at Scopus
  73. J. Huot, F. Houle, S. Rousseau, R. G. Deschesnes, G. M. Shah, and J. Landry, “SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis,” Journal of Cell Biology, vol. 143, no. 5, pp. 1361–1373, 1998. View at Publisher · View at Google Scholar · View at Scopus
  74. M. D. Esposti, J. Tour, S. Ouasti et al., “Fas death receptor enhances endocytic membrane traffic converging into the golgi region,” Molecular Biology of the Cell, vol. 20, no. 2, pp. 600–615, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. M. V. Blagosklonny, P. Giannakakou, W. S. El-Deiry et al., “Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death,” Cancer Research, vol. 57, no. 1, pp. 130–135, 1997. View at Google Scholar · View at Scopus
  76. S. Thébault, D. Gilbert, M. Hubert et al., “Orderly pattern of development of the autoantibody response in (New Zealand White × BXSB)F1 lupus mice: characterization of target antigens and antigen spreading by two-dimensional gel electrophoresis and mass spectrometry,” The Journal of Immunology, vol. 169, no. 7, pp. 4046–4053, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. E. Ortona, A. Capozzi, T. Colasanti et al., “Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome,” Blood, vol. 116, no. 16, pp. 2960–2967, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Katsumoto, A. Mitsushima, and T. Kurimura, “The role of the vimentin intermediate filaments in rat 3Y1 cells elucidated by immunoelectron microscopy and computer-graphic reconstruction,” Biology of the Cell, vol. 68, no. 2, pp. 139–146, 1990. View at Publisher · View at Google Scholar · View at Scopus
  79. R. D. Goldman, S. Khuon, Y. H. Chou, P. Opal, and P. M. Steinert, “The function of intermediate filaments in cell shape and cytoskeletal integrity,” Journal of Cell Biology, vol. 134, no. 4, pp. 971–983, 1996. View at Publisher · View at Google Scholar · View at Scopus
  80. E. Moisan and D. Girard, “Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis,” Journal of Leukocyte Biology, vol. 79, no. 3, pp. 489–498, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. E. Boilard, S. G. Bourgoin, C. Bernatchez, and M. E. Surette, “Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2,” Blood, vol. 102, no. 8, pp. 2901–2909, 2003. View at Publisher · View at Google Scholar · View at Scopus
  82. N. Mor-Vaknin, A. Punturieri, K. Sitwala, and D. M. Markovitz, “Vimentin is secreted by activated macrophages,” Nature Cell Biology, vol. 5, no. 1, pp. 59–63, 2003. View at Publisher · View at Google Scholar · View at Scopus
  83. T. J. Podor, D. Singh, P. Chindemi et al., “Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface,” The Journal of Biological Chemistry, vol. 277, no. 9, pp. 7529–7539, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. B. Xu, R. M. deWaal, N. Mor-Vaknin, C. Hibbard, D. M. Markovitz, and M. L. Kahn, “The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature,” Molecular and Cellular Biology, vol. 24, no. 20, pp. 9198–9206, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. A. E. Bryant, C. R. Bayer, J. D. Huntington, and D. L. Stevens, “Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes,” The Journal of Infectious Diseases, vol. 193, no. 12, pp. 1685–1692, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. P. Traub, G. Perides, H. Schimmel, and A. Scherbarth, “Interaction in vitro of nonepithelial intermediate filament proteins with total cellular lipids, individual phospholipids, and a phospholipid mixture,” The Journal of Biological Chemistry, vol. 261, no. 23, pp. 10558–10568, 1986. View at Google Scholar · View at Scopus
  87. C. Alessandri, M. Sorice, M. Bombardieri et al., “Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis,” Arthritis Research and Therapy, vol. 8, article no. R180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Degli Esposti, “Lipids, cardiolipin and apoptosis: a greasy licence to kill,” Cell Death and Differentiation, vol. 9, no. 3, pp. 234–236, 2002. View at Publisher · View at Google Scholar · View at Scopus
  89. L. A. Casciola-Rosen, G. Anhalt, and A. Rosen, “Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes,” Journal of Experimental Medicine, vol. 179, no. 4, pp. 1317–1330, 1994. View at Publisher · View at Google Scholar · View at Scopus
  90. A. Lanzavecchia, “How can cryptic epitopes trigger autoimmunity?” Journal of Experimental Medicine, vol. 181, no. 6, pp. 1945–1948, 1995. View at Publisher · View at Google Scholar · View at Scopus
  91. L. Casciola-Rosen, A. Rosen, M. Petri, and M. Schlissel, “Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 4, pp. 1624–1629, 1996. View at Publisher · View at Google Scholar · View at Scopus
  92. G. R. V. Hughes, “The anticardiolipin syndrome,” Clinical and Experimental Rheumatology, vol. 3, no. 4, pp. 285–286, 1985. View at Google Scholar · View at Scopus
  93. A. A. Manfredi, P. Rovere, G. Galati et al., “Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies,” Arthritis and Rheumatism, vol. 41, no. 2, pp. 205–214, 1998. View at Publisher · View at Google Scholar · View at Scopus
  94. A. A. Manfredi, P. Rovere, S. Heltai et al., “Apoptotic cell clearance in systemic lupus erythematosus. II. Role of β2-glycoprotein I,” Arthritis & Rheumatism, vol. 41, no. 2, pp. 215–223, 1998. View at Google Scholar · View at Scopus
  95. M. Sorice, T. Griggi, A. Circella et al., “Detection of antiphospholipid antibodies by immunostaining on thin layer chromatography plates,” Journal of Immunological Methods, vol. 173, no. 1, pp. 49–54, 1994. View at Publisher · View at Google Scholar · View at Scopus
  96. W. Lim, “Antiphospholipid syndrome,” Hematology, vol. 2013, pp. 675–680, 2013. View at Publisher · View at Google Scholar · View at Scopus
  97. E. J. Favaloro and R. C. Wong, “Antiphospholipid antibody testing for the antiphospholipid syndrome,” Pathology, vol. 46, no. 6, pp. 481–495, 2014. View at Publisher · View at Google Scholar
  98. H. P. McNeil, R. J. Simpson, C. N. Chesterman, and S. A. Krilis, “Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-Glycoprotein I (apolipoprotein H),” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 11, pp. 4120–4124, 1990. View at Publisher · View at Google Scholar · View at Scopus
  99. E. Matsuura, Y. Igarashi, M. Fujimoto, K. Ichikawa, and T. Koike, “Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease,” The Lancet, vol. 336, no. 8708, pp. 177–178, 1990. View at Publisher · View at Google Scholar · View at Scopus
  100. M. A. Blaschek, M. Boehme, J. Jouquan et al., “Relation of antivimentin antibodies to anticardiolipin antibodies in systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 47, no. 9, pp. 708–716, 1988. View at Publisher · View at Google Scholar · View at Scopus
  101. H. S. Leong, B. M. Mahesh, J. R. Day et al., “Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor,” Journal of Leukocyte Biology, vol. 83, no. 2, pp. 263–271, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. T. J. Podor, D. Singh, P. Chindemi et al., “Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface,” Journal of Biological Chemistry, vol. 277, no. 9, pp. 7529–7539, 2002. View at Publisher · View at Google Scholar · View at Scopus
  103. W. Emlen, J. Niebur, and R. Kadera, “Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus,” The Journal of Immunology, vol. 152, no. 7, pp. 3685–3692, 1994. View at Google Scholar · View at Scopus
  104. F. Conti, A. Capozzi, S. Truglia et al., “The mosaic of ‘seronegative’ antiphospholipid syndrome,” Journal of Immunology Research, vol. 2014, Article ID 389601, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus